Asset
LIFIRAFENIB
BeOne Medicines Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02610361 | phase1 | completed | 2013-11-20 | 2017-10-01 | BeiGene | Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors |
| NCT03641586 | phase1 | completed | 2015-10-12 | 2016-12-06 | BeiGene | The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor |
FDA applications (0)
This company has no applications containing this asset.